Caley Castelein's Net Worth
$17.4 Million
Who is Caley Castelein?
Caley Castelein has an estimated net worth of $17.4 Million. This is based on reported shares across multiple companies, which include ViewRay, Inc., Aadi Bioscience, Inc., Neos Therapeutics, Inc., and Tourmaline Bio, Inc..
SEC CIK
Caley Castelein's CIK is 0001355758
Past Insider Trading and Trends
2021 was Caley Castelein's most active year for acquiring shares with 10 total transactions. Caley Castelein's most active month to acquire stocks was the month of May. 2015 was Caley Castelein's most active year for disposing of shares, totalling 3 transactions. Caley Castelein's most active month to dispose stocks was the month of June. 2018 saw Caley Castelein paying a total of $5,158,167.78 for 867,296 shares, this is the most they've acquired in one year. In 2023 Caley Castelein cashed out on 2,345,030 shares for a total of $165,380.91, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ViewRay, Inc. (VRAYQ) Snapshot price: $0.000001
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -95.95% | -2.35M |
$0.07 | -$165,380.91 | 99.05K |
Jul 19
| |||
Form 4
| +1.88% | 16.59K |
$4.40 | $72,996.00 | 898.48K |
Jan 3
| |||
Form 4
| +6.59% | 54.51K |
—
|
—
| 881.89K |
Jun 13
| |||
Form 4
| +1,083.46% | 1.42M |
$2.54 | $3,601,119.00 | 1.55M |
May 10 - May 11
| |||
Form 4
| +1.53% | 12.52K |
$5.83 | $72,997.43 | 828.38K |
Jan 3
| |||
Form 4
| +2.61% | 20.76K |
$5.82 | $5,831.64 | 815.86K |
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +1.42% | 11.1K |
$5.82 | $64,628.02 | 795.1K |
Dec 31 - Jan 4
| |||
Form 4
| +7.21% | 52.75K |
—
|
—
| 783.99K |
Jun 15
| |||
Form 4
| +3.96% | 28K |
$4.06 | $61,996.90 | 734.63K |
Jan 2
| |||
Form 4
| +4.24% | 28.73K |
$6.16 | $61,994.24 | 706.63K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
| +306.00% | 510.93K |
$9.98 | $5,099,071.42 | 677.9K |
Aug 17
| |||
Form 4
| +1.91% | 3.13K |
$8.18 | $25,636.12 | 166.97K |
Aug 2
| |||
Form 4
| +2.50% | 4K |
$7.12 | $28,494.24 | 163.84K |
Jul 2
| |||
Form 4
| +5.34% | 8.1K |
—
|
—
| 159.83K |
Nov 15
| |||
Form 4
| +86.07% | 130.6K |
$6.44 | $841,064.00 | 282.33K |
Oct 25
| |||
Form 4
| +601.64% | 130.1K |
—
|
—
| 151.73K |
May 18
| |||
Form 4
|
∞
| 21.63K |
—
|
—
| 21.63K |
Sep 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aadi Bioscience, Inc. (AADI) Snapshot price: $1.7425
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
| +92.31% | 240K |
$12.50 | $3,000,000.00 | 500K |
Sep 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
∞
| 260K |
$13.08 | $3,399,993.85 | 260K |
Aug 26 - Aug 27
| |||
Form 4
| +2.72% | 7.81K |
$1.52 | $11,872.72 | 295.41K |
Jun 30
| |||
Form 4
| +2.75% | 7.7K |
$1.54 | $11,874.93 | 287.6K |
Mar 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 18
| |||
Form 4
| -82.66% | -1.33M |
—
|
—
| 279.91K |
Sep 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4
| +33.02% | 400K |
$5.00 | $2,000,000.00 | 1.61M |
Mar 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Neos Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
∞
| 1.22M |
—
|
—
| 1.22M |
Jul 28
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tourmaline Bio, Inc. (TRML) Snapshot price: $35.41
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 5
| |||
Form 4
| +4.03% | 20K |
$14.03 | $280,584.00 | 516.52K |
Oct 25 - Oct 27
| |||
Form 4
|
∞
| 954.56K |
—
|
—
| 954.56K |
Oct 19 - Oct 23
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||